ECCO 2017 | Status of molecular imaging for prostate cancer
Stefano Fanti, MD of University of Bologna, Bologna, Italy talks about the status of molecular imaging for prostate cancer. According to Dr Fanti, there has not been much research into imaging procedures for prostate cancer. However, multiparametric magnetic resonance imaging (MRI) and functional MRI are now available as well as new radiopharmaceuticals that can help us see prostate cancer and its recurrence at an early stage, which can help guide treatment.
Recorded at the European Cancer Congress of the European Cancer Organisation (ECCO) 2017 in Amsterdam, Netherlands.
Get great new content delivered to your inboxSign up